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Abstract
In the present study, we evaluated the relationship between nutritional status, disease stage and quality of life (QoL) in 100 patients
recently diagnosed with gastric carcinoma. The patients’ nutritional status was investigated with anthropometric, biochemical, inflammatory
and functional variables; and we also evaluated the nutritional risk with the Nutritional Risk Screening 2002. Oncological staging was stan-
dard. QoL was evaluated using the Functional Assessment of Anorexia/Cachexia Therapy questionnaire. The statistical correlation between
nutritional risk score (NRS) and oncological characteristics or QoL was evaluated using both univariable and multivariable analyses. Weight
loss and reduction of food intake were the most frequent pathological nutritional indicators, while biochemical, inflammatory and
functional variables were in the normal range. According to NRS, thirty-six patients were malnourished or at risk for malnutrition. Patients
with NRS $ 3 presented a significantly greater percentage of stage IV gastric cancer and pathological values of C-reactive protein, while no
correlation was found with the site of tumour. NRS was negatively associated with QoL (P,0·001) and this relation was independent from
oncological and inflammatory variables as confirmed by multivariable analysis. In the present study, we found that in patients with gastric
cancer malnutrition is frequent at diagnosis and this is likely due to reduction in food intake. Moreover, NRS is directly correlated with
tumour stage and inversely correlated with QoL, which makes it a useful tool to identify patients in need of an early nutritional intervention
during oncological treatments.
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Gastric cancer is one of the most common tumours in Europe,
with an estimated 160 000 new cases per year and approxi-
mately 120 000 deaths as reported in 2006. Although there is
a consistent downward trend in incidence and mortality, gas-
tric cancer remains the second leading cause of death from
cancer in the world(1).
For patients with localised disease, surgical resection is
the chosen treatment, while perioperative neoadjuvant or
adjuvant chemotherapy is indicated in more advanced stages
of gastric carcinoma(2).
The effects of gastro resection or gastrectomy and che-
motherapy on the nutritional status of the patients are well
known(3). Patients with gastric cancer are at very high risk
of deterioration of their nutritional status during the period
of oncological treatment because of iatrogenic causes in
addition to the disease itself. Thus, malnutrition is very
common in patients with gastric cancer. The incidence
ranges from 65 to 85 % of the cases(4) depending on the
methods used to evaluate nutritional status, disease stage
and oncological treatments. Malnutrition in cancer patients
was reported to affect tolerance to treatments, as well as
survival and quality of life (QoL). Nutritional screening is
important for most types of cancer(5) and it is crucial in gastric
cancer patients to start a timely nutritional intervention.
The specific aim of the present study was to analyse the
nutritional status of patients recently diagnosed with gastric
cancer before starting any treatment. The nutritional status
was evaluated by measuring anthropometric, biochemical,
inflammatory and functional variables. We also applied the
Nutritional Risk Screening 2002 and investigated whether
there were correlations between nutritional risk score (NRS),
site and stage of stomach cancer and QoL of the patients.
The present study is part of a more comprehensive
programme for surgical and medical patients with gastric
*Corresponding author: Dr C. Gavazzi, fax þ39 2 23902962, email cecilia.gavazzi@istitutotumori.mi.it
Abbreviations: CRP, C-reactive protein; NRS, nutritional risk score; QoL, quality of life.
British Journal of Nutrition (2011), 106, 1773–1778 doi:10.1017/S0007114511002509
q The Authors 2011
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114511002509
Downloaded from https:/www.cambridge.org/core. NATO Defence College, on 23 Mar 2017 at 11:31:09, subject to the Cambridge Core terms of use, available at
cancer, where the overall purpose of nutritional screening is to
identify patients who will need nutrition support during the
entire oncological treatment.
Patients and methods
Study design
The investigation was a one-centre open, prospective clinical
study, approved by the National Cancer Institute Ethics Com-
mittee and performed in accordance with the guidelines laid
down in the Declaration of Helsinki.
All gastric cancer patients consecutively admitted to surgical
or medical wards between January 2008 and June 2009 were
assessed by a single trained dietitian within 2 d after hospital
admission. Only patients with proven diagnosis of gastric
adenocarcinoma were included in the study, after signing an
informed consent. Exclusion criteria were previous oncologi-
cal treatment, presence of severe disease that interferes with
nutritional status (cirrhosis, chronic obstructive lung disease,
chronic renal or intestinal failure, stroke or other neurological
disease), upper limb deformities and incapacity to perform the
hand grip strength test.
Oncological characteristics
Tumour site was determined by endoscopic examination;
tumour histology was analysed on a surgical or endoscopic spe-
cimen and was defined according to Lauren’s classification(6);
the stage of the disease was estimated according to the Inter-
national Union Against Cancer’s tumour-node-metastasis
system (2002) and the American Joint Committee on Cancer
stage grouping.
Nutritional status
Nutritional status was evaluated using anthropometric,
biochemical and functional indicators. The nutritional risk
screening was performed according to the European Society
for Clinical Nutrition and Metabolism recommendations(7),
using the NRS 2002(8), in which nutritional risk is evaluated
considering both the nutritional status and the severity of
the disease. Recent weight loss, BMI and food intake in the
preceding week are the nutritional variables considered.
One point is given for weight loss . 5 % in 3 months or
food intake between 50 and 75 %; two points are given if
weight loss . 5 % is reported in 2 months or food intake is
between 25 and 50 % or BMI is between 18·5 and 20·5 with
impaired general condition; three points are given in patients
where weight loss . 5 % is reported in 1 month or food intake
is almost nil (i.e. , 25 %) or BMI is , 18·5 with impaired
general condition. For all patients the nutritional status
score is incremented by one point for the presence of
cancer and an additional point was added for patients with
age $ 70 years. Patients were classified as high risk when
NRS $ 3 and as low risk for NRS , 3.
Biochemical variables were analysed using blood
samples collected on the first day of hospitalisation and
included total protein, albumin, lymphocytes and C-reactive
protein (CRP).
Functional assessment was performed using a Jamar hand
grip dynamometer (Bolingbrook, IL, USA). Patients were
asked to sit in a comfortable position with elbows on a table
and to grip the dynamometer two times with their dominant
hand, the second measurement was recorded. Grip strength
measurements were compared to age and sex standard
values(9) and were expressed as percentage of these standard
values. Grip strength measurements were considered in the
normal range when $ 85 %, as recommended by Webb et al.(10)
Quality of life
QoL was investigated using the official Italian translation of
the self-administrated Functional Assessment of Anorexia/
Cachexia Therapy(11), a QoL scoring system that focuses on
specific nutritional issues (twelve items), in addition to physi-
cal and functional well-being (fourteen items) in cancer
patients (see Table 1). All responses are graded from 0 to 4.
Only questionnaires where the response rate was .85 %
were considered. A standardised score was calculated and
it ranged from 0 to 104, with 0 representing the worst and
104 representing the best QoL.
Statistical analysis
Based on literature findings(12–14), the proportion of malnour-
ished patients (weight loss .10 % of usual weight) is reported
Table 1. Quality of life questionnaire*
List of items
Physical well-being
1 I have a lack of energy
2 I have nausea
3 Because of my physical condition, I have trouble
meeting the needs of my family
4 I have pain
5 I am bothered by side effects of treatment
6 I feel ill
7 I am forced to spend time in bed
Functional well-being
1 I am able to work (include work at home)
2 My work (include work at home) is fulfilling
3 I am able to enjoy life
4 I have accepted my illness
5 I am sleeping well
6 I am enjoying the things I usually do for fun
7 I am content with the quality of my life right now
Additional concerns
1 I have a good appetite
2 The amount I eat is sufficient to meet my needs
3 I am worried about my weight
4 Most food tastes unpleasant to me
5 I am concerned about how thin I look
6 My interest in food drops as soon as I try to eat
7 I have difficulty eating rich or ‘heavy’ foods
8 My family or friends are pressuring me to eat
9 I have been vomiting
10 When I eat, I seem to get full quickly
11 I have pain in my stomach area
12 My general health is improving
* FAACT version 4; Elmhurst, IL, USA.
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ranging from about 20 to 50 %. We calculated that a sample
size of 100 patients could produce a two-sided 95 % CI with
a width ranging from 16·5 to 20·3 should the proportion be
within the earlier hypothesised range. Association between
NRS and oncological characteristics was analysed with univari-
able analysis using the x 2 test or Fisher’s test, when appropri-
ate, or with multivariable analysis. In the multivariable analysis
we included all the oncological parameters as covariates in a
binary logistic model; the model response variable was NRS
($3, ,3) and the association between NRS and the covariates
was tested by two-sided Wald tests. In the afore-mentioned
analyses, the NRS adjustment for patients with age $ 70
years was not performed.
The association between the QoL score and NRS was
studied using the Kruskal–Wallis or the Mann–Whitney test,
when appropriate. To study an independent effect of nutri-
tional status on QoL, we performed a multivariable general
linear regression analysis, in which the response variable
was QoL score and the covariates were NRS, CRP and
tumour stage.
P values ,0·05 were considered statistically significant.
The SAS statistical package (Cary, NC, USA)(15) and R software
(Vienna, Austria)(16) were used for the statistical analysis.
Results
A total of 105 patients were screened from January 2008 to
June 2009. Patients (n 2) were excluded because of previous
oncological treatment, three patients were excluded because
of the presence of associated severe diseases other than
cancer. In all, 100 patients were included in the study (male/
female 60:40, mean age 64 (SD 13·5) years). The nutritional
parameters are shown in Table 2. Considering all patients
together (column 1) mean BMI was at the higher limit of
normal values, only sixteen patients presented a BMI below
normal range. Weight loss was observed in a higher number
of patients as compared with other nutritional variables. Actu-
ally thirty-five patients showed a weight loss $ 5 % of their
usual weight in the preceding 3 months. Of these patients,
seventeen had a weight loss .10 % (17 % of the overall
sample; 95 % CI 10·2, 25·8). A total of twenty-nine patients
reported a reduction of food intake in the previous week
and among those, eight patients reported food intake that
was ,25 % of requirement. Mean values of biochemical
indicators and hand grip strength were all in the normal range.
According to NRS, thirty-six patients were malnourished or
at risk for malnutrition. Nutritional characteristics according
to NRS are also shown in Table 2 (columns 2 and 3). No differ-
ence was found in mean values of biochemical indicators or in
the hand grip strength between the two groups. CRP mean
value was normal in patients with NRS , 3 and it was slightly
above the normal range in patients with NRS $ 3. This differ-
ence was not statistically significant; however, the percentage
of patients with CRP . 10 mg/l was significantly greater in
patients with NRS $ 3 compared with patients with NRS , 3
(48 v. 22 %; x 2 test P¼0·023).
The majority of tumours were localised in the middle part of
the stomach, i.e. fundus and body, while thirty-nine patients
presented a tumour originating in the antrum. According to
Lauren’s classification, the most common histological type
was the diffused form and 70 % of patients presented a
poorly differentiated form. A total of twenty-nine and thirty
patients were diagnosed with locally advanced tumours,
classified as stage III and stage IV, respectively.
Regarding the association between nutritional risk and
oncological characteristics, univariable analysis showed a
significant result only for tumour stage (P,0·001), but not
for tumour site or grade. Compared with low-risk patients,
high-risk patients had a greater percentage of stage IV
tumours (53·3 v. 20·0 %; P,0·001). In multivariable analysis,
the association between NRS and tumour stage was also
significant (P¼0·005).
QoL questionnaires were evaluable in eighty-seven patients.
QoL score values tended to be inversely associated with NRS
as median values of QoL score (interquartile range) were
84·6 (80·0–89·9) for NRS ¼ 1 (thirty-seven patients), 80·0
(74·0–85·5) for NRS ¼ 2 (twenty-one patients), 79·0 (68·4–
80·6) for NRS ¼ 3 (thirteen patients), 49·2 (40·3–62·0) for
NRS ¼ 4 (eight patients) and 59·6 (48·2–76·2) for NRS ¼ 5
(eight patients) (Kruskal–Wallis test P,0·001).
This negative association between QoL score and NRS was
confirmed as significant when stratifying patients based
on low (NRS , 3) or high nutritional risk (NRS $ 3). The
median values of QoL score (interquartile range) were 83·0
(77·5–88·4) for NRS , 3 (fifty-eight patients) and 68·3 (49·2–
78·0) for NRS $ 3 (twenty-nine patients) (Fig. 1; Mann–
Whitney test P,0·001).
In the multivariable general linear regression analysis,
NRS was demonstrated as an independent predictor of QoL
score (F test P¼0·0002), whereas CRP and tumour stage
were not significantly associated with QoL (P¼0·393 and
0·086, respectively).
Discussion
Malnutrition has been recognised as an important prognostic
factor in cancer patients since 1980, when Dewys et al.(12)
reported a shorter survival in malnourished compared with
well-nourished patients, with this being particularly true for
patients with gastric cancer undergoing chemotherapy.
Despite these early observations, only few studies analysed
the nutritional status at the beginning of the oncological
treatment and focused mostly on surgical patients.
A weight loss .10 % of usual weight is considered an indi-
cator of severe malnutrition and was reported in 33 % out of
317 patients affected by advanced gastric adenocarcinoma in
the study by Dewys et al.(12). In smaller and heterogeneous
groups of gastric cancer patients, significant weight loss was
reported ranging from 21·6 to 50 %(13,14).
In our analysis, severe weight loss ($10 % of usual weight)
was recorded in only 17 % of the patients and this percentage
was similar to the one recently published by Pacelli et al.(17)
in patients undergoing surgery. Furthermore, data showed
normal values of albumin, suggesting that simple reduction
of food intake rather than a wasting syndrome was the
major cause of weight loss in the initial clinical oncological
Nutritional screening in gastric cancer 1775
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Table 2. Nutritional characteristic overall and according to nutritional risk score (NRS)
(Mean values and standard deviations)
Overall (n 100) NRS , 3* (n 64) NRS $ 3* (n 36)
Characteristics† Mean SD Mean SD Mean SD
Weight (kg) 68·5 12·2 72·6a 10·1 61·2b 12·5
BMI (kg/m2) 24·8 3·8 26·1a 3·2 22·6b 3·9
Pts with BMI , 18·5 kg/m2
n 4 1 3
% 1·6 8·3
BMI ¼ 18·6–20·5 kg/m2
n 12 3 9
% 4·7 25·0
BMI ¼ 20·6–25 kg/m2
n 34 22 12
% 34·4 33·3
BMI . 25 kg/m2
n 50 38 12
% 59·4 33·3
Weight loss (%)‡ 4·6 5·7 1·4a 2·7 10·4b 5
Pts with weight loss
n 35 5 30
% 7·8 83·3
. 5 % in 3 months
n 9 5 4
% 7·8 11·1
. 5 % in 2 months
n 14 0 14
% 0·0 38·9
. 5 % in 1 month
n 12 0 12
% 0·0 33·3
$ 10 %
n 17 2 15
% 3·1 41·7
Food intake
Pts with food intake reduction
n 29 3 26
% 4·7 72·2
Food intake 51–75 %§
n 11 3 8
% 4·7 22·2
Food intake 26–50 %§
n 10 0 10
% 0·0 27·8
Food intake 0–25 %§
n 8 0 8
% 0·0 22·2
HGS (%)k 98·3 21·2 101·4 21·3 92·6 20·2
Pts with HGS , 85 %
n 22 15 7
% 23·4 19·4
Biochemical and inflammatory indicators
Total protein (g/l) 74 6·0 75 5·0 72 6·0
Albumin (g/l) 42 4·0 44 4·0 40 4·0
Lymphocytes (count £ 106/l) 1758 632 1765 609 1744 680
CRP (mg/l) 8·4 10·9 5·2 5·6 14·2 15·2
Pts with CRP . 10 mg/l
n 28 13 15
% 22{ 48{
Pts, patients; HGS, hand grip strength; CRP, C-reactive protein.
a,b Mean values within a row with unlike superscript letters were significantly different between categories (P,0·001).
* All participants have at least NRS score 1, since they have cancer.
† Nutritional assessment was within 2 d of admission and blood samples are from the first hospital day.
‡ Percentage of habitual weight.
§ Percentage of normal requirement.
k Percentage of standard values, as defined in the Methods section.
{ Calculated excluding missing data (n 11).
G. Gavazzi et al.1776
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history of patients with gastric cancer, although approximately
one third of patients had an initial increase of CRP values.
The main reason for evaluating the nutritional status in our
cohort was to identify patients that would need to be sup-
ported with nutritional therapy during oncological treatment.
As a tool to stratify patients in different groups, we applied
the NRS 2002, which is based on the analysis of 128 random-
ised clinical studies and it is meant to identify patients who
will probably benefit from nutritional support. NRS combines
degrees of undernutrition with degrees of severity of disease.
The criteria of exclusion that we adopted allowed us to give to
all patients the same score for the severity of disease, i.e. one
point for the oncological pathology. NRS has been largely
used to predict surgical complication and to monitor nutri-
tional status after curative gastric surgery(18,19). The association
between nutritional risk and clinical outcome has also been
demonstrated in a large cohort of patients including different
types of cancer(20). However, the relation between NRS and
cancer stage has not yet been investigated. The present
study, although considering a relatively small sample, evalu-
ated a very homogeneous cohort of patients with a recent
diagnosis of gastric carcinoma.
The analysis performed in the present study highlighted the
correlation between patients with gastric tumours and NRS.
We found a significant correlation between disease stage
and NRS (P¼0·005 at multivariable analysis) while no corre-
lation was observed between NRS and tumour site.
Furthermore, 60 % of patients with NRS 4 or 5 were candi-
dates for chemotherapy to reduce the tumour burden.
Owing to a high degree of malnutrition, these patients were
reported to suffer from a higher rate of side effects that limit
the completion of the scheduled therapies(21). We, therefore,
strongly suggest that these patients should undergo adequate
nutritional support during oncological treatments.
The relationship between nutritional status and QoL in
cancer patients has been well described by Marı´n Caro
et al.(22). The presence of the tumoural mass and the side
effects of the oncological treatments have an impact on several
parameters, such as food intake, absorption and metabolic
alterations, which alter the nutritional status and interfere
with the QoL. Among patients with different types of tumours
and therapeutic interventions Ravasco et al.(23) reported that
patients with stomach and oesophagus cancer had the worst
QoL as assessed with the European Organisation for Research
and Treatment of Cancer Quality of Life Questionnaire.
In patients that had total gastrectomy because of stomach
cancer Tian & Chen(24) demonstrated that there was a statisti-
cal correlation between the daily nutrition intake and QoL,
suggesting that even after surgical treatment the nutritional
status deteriorates and influences negatively the QoL. The
interesting results in the present study show that the relation-
ship between NRS and QoL starts very early in patients
affected by gastric cancer, even before starting any oncological
treatment and it is independent from oncological character-
istics, as demonstrated by the multivariable general linear
regression analysis.
Acknowledgements
The authors report no conflict of interest. All the authors made
significant contributions and specific responsibilities were
as follows: C. G. study design, interpretation of results and
drafting the manuscript; S. C. assessment of patients, data
collection and analysis; A. S. review of oncological data;
V. M. recruitment of patients; R. M. statistical analysis and
drafting the manuscript. This research received no specific
grant from any funding agency in the public or commercial
sector. V. M. was partially supported by the Italian Association
for Cancer Research. We wish to thank all patients included in
the study, Anna Armonti, Franca Filincieri, Carmen Maiorana
and Lorena Riva, for their help in data collection and Fabio
Stossi (University of Illinois at Urbana–Champaign) for the
assistance in English revision.
References
1. Ferlay J, Autier P, Boniol M, et al. (2007) Estimates of the
cancer incidence and mortality in Europe in 2006. Ann
Oncol 18, 581–592.
2. Morabito A, Carillio G & Longo R (2009) Systemic treatment
of gastric cancer. Crit Rev Oncol Hematol 70, 216–234.
3. Vandebroek AJ & Schrijvers D (2008) Nutritional issues in
anti-cancer treatment. Ann Oncol 19, Suppl. 5, v52–v55.
4. Stratton RJ, Green CJ & Elia ME (2003) Disease Related
Malnutrition: An Evidence-based Approach to Treatment.
Wallingford: CAB International.
5. Huhmann MB & Cunningham RS (2005) Importance of
nutritional screening in treatment of cancer-related weight
loss. Lancet Oncol 6, 334–343.
6. Lauren P (1965) The two histological main types of gastric
carcinoma: diffuse and so-called intestinal-type carcinoma.
An attempt at a histo-clinical classification. Acta Pathol
Microbiol Scand 64, 31–49.
7. Kondrup J, Allison SP, Elia M, et al. (2003) ESPEN guidelines
for nutrition screening 2002. Clin Nutr 22, 415–421.
100
90
80
70
Q
o
L 
sc
o
re
60
50
40
30
<3
NRS
≥3
Fig. 1. Quality of life (QoL) score v. nutritional risk score (NRS). Each
‘box-plot’ shows some descriptive statistics of QoL score, i.e. (from bottom to
top line): 1st quartile, median (bold line), 3rd quartile and maximum value.
The circle represents one extreme value. Patients with NRS $ 3 (twenty-nine
patients) presented lower QoL score values as compared with patients with
NRS , 3 (fifty-eight patients).
Nutritional screening in gastric cancer 1777
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114511002509
Downloaded from https:/www.cambridge.org/core. NATO Defence College, on 23 Mar 2017 at 11:31:09, subject to the Cambridge Core terms of use, available at
8. Kondrup J, Rasmussen HH, Hamberg O, et al. (2003)
Nutritional Risk Screening (NRS 2002): a new method
based on an analysis of controlled clinical trials. Clin Nutr
22, 321–336.
9. Mathiowetz V, Kashman N, Volland G, et al. (1985) Grip and
pinch strength: normative data for adults. Arch Phys Med
Rehabil 66, 69–74.
10. Webb AR, Newman LA, Taylor M, et al. (1989) Hand grip
dynamometry as a predictor of postoperative complications
reappraisal using age standardized grip strengths. J Parenter
Enteral Nutr 13, 30–33.
11. Ribaudo JM, Cella D, Hahn EA, et al. (2001) Re-validation
and shortening of the Functional Assessment of Anorexia/
Cachexia Therapy (FAACT) questionnaire. Qual Life Res 9,
1137–1146.
12. Dewys WD, Begg C, Lavin PT, et al. (1980) Prognostic effect
of weight loss prior to chemotherapy in cancer patients.
Eastern Cooperative Oncology Group. Am J Med 69,
491–497.
13. Farreras N, Artigas V, Cardona D, et al. (2005) Effect of early
postoperative enteral immunonutrition on wound healing in
patients undergoing surgery for gastric cancer. Clin Nutr 24,
55–65.
14. Correia M, Cravo M, Marques-Vidal P, et al. (2007) Serum
concentrations of TNF-alpha as a surrogate marker for
malnutrition and worse quality of life in patients with gastric
cancer. Clin Nutr 26, 728–735.
15. SAS (1990) Procedures Guide, version 6, 3rd ed. Cary, NC:
SAS Institute, Inc.
16. R Development Core Team (2007) R: A Language and
Environment for Statistical Computing. Vienna: R Foundation
for Statistical Computing. http://www.R-project.org (accessed
10 November 2009).
17. Pacelli F, Bossola M, Rosa F, et al. (2008) Is malnutrition still
a risk factor of postoperative complications in gastric cancer
surgery? Clin Nutr 27, 398–407.
18. Schiesser M, Mu¨ller S, Kirchhoff P, et al. (2008) Assessment
of a novel screening score for nutritional risk in predicting
complications in gastro-intestinal surgery. Clin Nutr 27,
565–570.
19. Ryu SW & Kim IH (2010) Comparison of different nutrition
assessments in detecting malnutrition among gastric cancer
patients. World J Gastroenterol 16, 3310–3317.
20. Sorensen J, Kondrup J, Prokopowicz J, et al. (2008)
EuroOOPS: an international, multicentre study to implement
nutritional risk screening and evaluate clinical outcome.
Clin Nutr 27, 340–349.
21. Andreyev HJ, Norman AR, Oates J, et al. (1998) Why do
patients with weight loss have a worse outcome when
undergoing chemotherapy for gastrointestinal malignancies?
Eur J Cancer 34, 503–509.
22. Marı´n Caro MM, Laviano A & Pichard C (2007) Impact of
nutrition on quality of life during cancer. Curr Opin Clin
Nutr Metab Care 10, 480–487.
23. Ravasco P, Monteiro-Grillo I, Vidal PM, et al. (2004) Cancer:
disease and nutrition are key determinants of patients’
quality of life. Support Care Cancer 12, 246–252.
24. Tian J & Chen JS (2005) Nutritional status and quality of life
of the gastric cancer patients in Changle County of China.
World J Gastroenterol 11, 1582–1586.
G. Gavazzi et al.1778
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114511002509
Downloaded from https:/www.cambridge.org/core. NATO Defence College, on 23 Mar 2017 at 11:31:09, subject to the Cambridge Core terms of use, available at
